Overview
- The £20m AHG Catalysing Innovation Awards have opened, led by the Office for Life Sciences and delivered through Innovate UK.
- Funding is split between up to £10m for late‑stage, high‑impact projects and up to £1.5m for earlier‑stage innovations.
- Eligible solutions span new medicines, medical devices, wearable tech, AI tools, virtual reality therapies and treatment apps.
- Winners receive an exclusive MHRA/NICE education session to navigate evidence requirements and the route to UK certification and roll‑out.
- Applications close 6 May 2026, with an online briefing for prospective bidders on 19 February.